SRx Health raises $15.23M in first closing of Series A preferred offering; secures up to $1B equity commitment

SRx Health Solutions, Inc.

• First closing of private placement: 19,035 Series A Preferred shares and 54.5M warrants for $15.23M; additional closings at investor option up to $30.46M total.
• Amendment to July 2025 Purchase Agreement increased total commitment from $50M to $1B; issued $20M convertible promissory note in connection.
• Series A Preferred conversion price fixed at $0.6109; warrants exercisable at $0.6109; company seeks stockholder approval to raise authorized common from 200M to 5B shares.
• Directors Lionel F. Conacher and David Allen White resigned Oct 31, 2025; committees reconstituted with Michael Young, Simon Conway and Joshua A. Epstein.